Abstract:Homo sapiens longevity assurance homologue 2 (LASS2) is a novel gene isolated from a human liver cDNA library by our laboratory, and it is a human homologue of the yeast longevity assurance gene LAG1 (Saccharomyces cerevisiae longevity assurance gene). According to our previous results, LASS2 could interact with subunit c of vacuolar type H(+)-ATPase (V-ATPase), and the overexpression of LASS2 could inhibit the cell growth of a human hepatocellular carcinoma (HCC) cell line, SMMC-7721. In order to understand the role of the interaction between LASS2 and V-ATPase in HCC cell growth, we transiently transfected plasmid pCMV-HA2-LASS2 into HCCLM3, a HCC cell line without the significant expression of endogenous LASS2. The pH-sensitive fluorescence probes, BCECF and BCECF-AM, were used to measure the intracellular and extracellular H(+) concentrations of HCCLM3 cells respectively. The effect of LASS2 gene on apoptosis was evaluated with Annexin-V/FITC and propidium iodide (PI) by flow cytometry. Western blot was used to detect cytochrome c (Cyt c) in the cytosol and mitochondria, as well as pro-caspase-3 in cytosol. The results showed that the cell growth of LASS2-transfected HCCLM3 cells was significantly inhibited compared with that of the mock control. LASS2 transfection increased intracellular H(+) concentration of HCCLM3 cells, while decreased extracellular H(+) concentration. Moreover, LASS2 transfection significantly enhanced the apoptosis of HCCLM3 cells. In LASS2-transfected cells, the amounts of Cyt c increased in the cytosol, while decreased in the mitochondria. Meanwhile, the expression of pro-caspase-3 in the cytosolic extracts was decreased. These results implicate that LASS2 gene might increase intracellular H(+) of HCC cells via the interaction with V-ATPase, thereby inducing cell apoptosis through mitochondrial pathway.

[LASS2 Interacts with V-ATPase and Inhibits Cell Growth of Hepatocellular Carcinoma].

Construction of LASS2 gene recombinant adenovirus and its effect on the inhibition of metastasis of hepatocellular carcinoma cell line HCCLM3

Small interfering RNA targeting LASS2 gene enhances invasion capacity of hepatocellular carcinoma cells

LASS2 Gene Inhibits the Metastasis of Human Hepatocellular Carcinoma HCCLM3 Cells

Bc047440 Antisense Eukaryotic Expression Vectors Inhibited Hepg(2) Cell Proliferation and Suppressed Xenograft Tumorigenicity

Mutation Analysis of Novel Human Liver-Related Putative Tumor Suppressor Gene in Hepatocellular Carcinoma

The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function.

LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity

Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma

Hepatocyte-specific Deletion of LASS2 Protects Against Diet-Induced Hepatic Steatosis and Insulin Resistance

Increased Long Noncoding RNA LASP1‐AS is Critical for Hepatocellular Carcinoma Tumorigenesis Via Upregulating LASP1

A Novel Tumor Metastasis Suppressor Gene LASS2/TMSG1 Interacts with Vacuolar ATPase Through Its Homeodomain.

LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump

Upregulation of SGOL2 Predicts Poor Prognosis and Facilitates Hepatocellular Carcinoma Progression via Dysregulating the Cell Cycle by Directly Activating MAD2

Leucine-rich Repeat and Sterile Alpha Motif Containing 1 Promotes the Oncogenic Growth of Human Hepatocellular Carcinoma Cells

Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer

Silencing of LASS2/TMSG1 Enhances Invasion and Metastasis Capacity of Prostate Cancer Cell

Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway

Silencing of a Novel Tumor Metastasis Suppressor Gene LASS2/TMSG1 Promotes Invasion of Prostate Cancer Cell in Vitro Through Increase of Vacuolar ATPase Activity

LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities Via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma

LCN2 Promotes Proliferation and Glycolysis by Activating the JAK2/STAT3 Signaling Pathway in Hepatocellular Carcinoma